Product logins

Find logins to all Clarivate products below.


Blog

Here you will find relevant articles and insight into all Clarivate related products and news.

Featured posts

Why longevity might be biopharma’s next big thing: The science and business converge Why longevity might be biopharma’s next big thing: The science and business converge
Blog March 2, 2026
Why longevity might be biopharma’s next big thing: The science and business converge
Why ease of administration in new drugs sometimes draws a yawn from payers Why ease of administration in new drugs sometimes draws a yawn from payers
Blog February 26, 2026
Why ease of administration in new drugs sometimes draws a yawn from payers
chevron_left
chevron_right
The competitive intelligence workflow problem in pharma: a diagnostic framework The competitive intelligence workflow problem in pharma: a diagnostic framework
Blog June 12, 2026
The competitive intelligence workflow problem in pharma: a diagnostic framework
Biopharma Business Development Dealmaking
Economic and geopolitical pressures shaping elective medtech markets in 2026 Economic and geopolitical pressures shaping elective medtech markets in 2026
Blog June 11, 2026
Economic and geopolitical pressures shaping elective medtech markets in 2026
Medtech
De-risking next-generation bispecific antibodies: a target-centric approach to safety intelligence De-risking next-generation bispecific antibodies: a target-centric approach to safety intelligence
Blog June 9, 2026
De-risking next-generation bispecific antibodies: a target-centric approach to safety intelligence
Bispecific antibodies BsAb Clinical trials
U.S. insured lives data reveal sharp changes as ACA era comes to a close U.S. insured lives data reveal sharp changes as ACA era comes to a close
Blog June 9, 2026
U.S. insured lives data reveal sharp changes as ACA era comes to a close
Biopharma Market Access Medtech
Balancing the promise of targeted protein degradation with real-world safety insights Balancing the promise of targeted protein degradation with real-world safety insights
Blog June 3, 2026
Balancing the promise of targeted protein degradation with real-world safety insights
One drug, seven names: the hidden complexity of pharmaceutical competitive intelligence data One drug, seven names: the hidden complexity of pharmaceutical competitive intelligence data
Blog June 2, 2026
One drug, seven names: the hidden complexity of pharmaceutical competitive intelligence data
Biopharma Dealmaking M&A
Three uncomfortable truths about cell and gene therapy in regulatory affairs Three uncomfortable truths about cell and gene therapy in regulatory affairs
Blog May 28, 2026
Three uncomfortable truths about cell and gene therapy in regulatory affairs
Consulting Resource Center Regulatory
The competitive signals hiding in plain sight for biopharma The competitive signals hiding in plain sight for biopharma
Blog May 8, 2026
The competitive signals hiding in plain sight for biopharma
Biopharma Business Development Clinical trials